Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk. Slomski A. JAMA 2021;326:2464.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Slomski A. Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk. JAMA 2021;326:2464.
PMID: 34962528